Menin-MLL inhibitors reverse oncogenic activity of MLL fusion proteins in leukemia

Por um escritor misterioso

Descrição

Menin-MLL inhibitors reverse oncogenic activity of MLL fusion proteins in  leukemia
A molecular switch between mammalian MLL complexes dictates
Menin-MLL inhibitors reverse oncogenic activity of MLL fusion proteins in  leukemia
MLL fusion proteins as targets for small molecule inhibition
Menin-MLL inhibitors reverse oncogenic activity of MLL fusion proteins in  leukemia
A novel Menin-MLL1 inhibitor, DS-1594a, prevents the progression
Menin-MLL inhibitors reverse oncogenic activity of MLL fusion proteins in  leukemia
A molecular switch between mammalian MLL complexes dictates
Menin-MLL inhibitors reverse oncogenic activity of MLL fusion proteins in  leukemia
Molecules, Free Full-Text
Menin-MLL inhibitors reverse oncogenic activity of MLL fusion proteins in  leukemia
MLL-fusion-driven leukemia requires SETD2 to safeguard genomic
Menin-MLL inhibitors reverse oncogenic activity of MLL fusion proteins in  leukemia
A Box of Chemistry to Inhibit the MEN1 Tumor Suppressor Gene
Menin-MLL inhibitors reverse oncogenic activity of MLL fusion proteins in  leukemia
Leukemogenesis via aberrant self‐renewal by the MLL/AEP‐mediated
Menin-MLL inhibitors reverse oncogenic activity of MLL fusion proteins in  leukemia
Trithorax and polycomb cooperation in MLL fusion acute leukemia
Menin-MLL inhibitors reverse oncogenic activity of MLL fusion proteins in  leukemia
Menin-MLL inhibitor MI-2 Epigenetic Reader Domain Inhibitor
Menin-MLL inhibitors reverse oncogenic activity of MLL fusion proteins in  leukemia
IJMS, Free Full-Text
Menin-MLL inhibitors reverse oncogenic activity of MLL fusion proteins in  leukemia
Challenges and opportunities in targeting the menin–MLL
Menin-MLL inhibitors reverse oncogenic activity of MLL fusion proteins in  leukemia
Recent Progress of Small Molecule Menin–MLL Interaction Inhibitors
de por adulto (o preço varia de acordo com o tamanho do grupo)